Effects of conjugated linoleic acid supplementation on serum leptin levels,oxidative stress factors and tumor marker in rectal cancer patients undergoing preoperative chemoradiotherapy
Restricted accessResearch articleFirst published online September 13, 2021
Effects of conjugated linoleic acid supplementation on serum leptin levels,oxidative stress factors and tumor marker in rectal cancer patients undergoing preoperative chemoradiotherapy
Inflammation is considered as one of the major factors in chemoradiotherapy toxicity. It has been reported that conjugated linoleic acid (CLA) has anti-inflammatory properties.
OBJECTIVE:
The aim of this study was to assess the effect of CLA supplementation on serum levels of leptin, interleukin 8 (IL-8), malondialdehyde (MDA), total antioxidant status (TAS), and carcinoembryonic antigen (CEA) in rectal cancer patients treated with chemoradiotherapy.
METHODS:
In this study, 34 rectal cancer patients were allocated to either the CLA group, who received four 1000 mg capsules (each capsule containing 760 mg CLA; 4 capsules providing 3 g CLA) 3 times/day, or the placebo group, who received 4 placebo capsules 3 times/day, for 6 weeks.
RESULTS:
The mean serum leptin level insignificantly increased in both groups; however, this elevation was remarkable in the CLA group. CLA supplementation reduced IL-8 by –0.62 pg/mL while placebo supplementation decreased it by –0.44 pg/mL. CEA levels were decreased by CLA supplementation, while its reduction in the placebo group was negligible compared to the CLA group. The elevation of MDA levels after CLA supplementation was about half of the placebo group in the CLA group.
CONCLUSION:
Since this study was the first to assess the effect of CLA supplementation on a small number of cancer patients, it is suggested further studies are conducted on larger sample size with various doses of CLA to obtain more clear results.
FerlayJ, SoerjomataramI, DikshitR, EserS, MathersC, RebeloM, et al.Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Inter J Cancer. 2015;136(5):E359–E86.
2.
BarbierM, CherbutC, AubeA, BlottiereH, GalmicheJ. Elevated plasma leptin concentrations in early stages of experimental intestinal inflammation in rats. Gut. 1998;43(6):783–90.
3.
KemikO, SumerA, KemikAS, HasirciI, PurisaS, DulgerAC, et al.The relationship among acute-phase response proteins, cytokines and hormones in cachectic patients with colon cancer. World J Surgical Oncol. 2010;8(1):85.
4.
FreemanHJ. Risk of gastrointestinal malignancies and mechanisms of cancer development with obesity and its treatment. Best Pract Res Clin Gastroenterol. 2004;18(6):1167–75.
5.
AndreN, SchmiegelW. Chemoradiotherapy for colorectal cancer. Gut. 2005;54(8):1194–202.
Serna-ThoméG, Castro-EguiluzD, Fuchs-TarlovskyV, Sánchez-LópezM, Delgado-OlivaresL, Coronel-MartínezJ, et al.Use of Functional Foods and Oral Supplements as Adjuvants in Cancer Treatment. Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion. 2018;70(3):136–46.
8.
CalvarusoM, PucciG, MussoR, BravatàV, CammarataFP, RussoG, et al.Nutraceutical compounds as sensitizers for cancer treatment in radiation therapy. Inter J Molecular Scien. 2019;20(21):5267.
9.
SangthawanD, PhungrassamiT, SinkitjarurnchaiW. A randomized double-blind, placebo-controlled trial of zinc sulfate supplementation for alleviation of radiation-induced oral mucositis and pharyngitis in head and neck cancer patients. J Med Assoc Thai. 2013;96(1):69–76.
10.
RipamontiC, ZeccaE, BrunelliC, FulfaroF, VillaS, BalzariniA, et al.A randomized, controlled clinical trial to evaluate the effects of zinc sulfate on cancer patients with taste alterations caused by head and neck irradiation. Cancer. 1998;82(10):1938–45.
11.
MeyerF, BairatiI, FortinA, GélinasM, NabidA, BrochetF, et al.Interaction between antioxidant vitamin supplementation and cigarette smoking during radiation therapy in relation to long-term effects on recurrence and mortality: a randomized trial among head and neck cancer patients. Inter J Cancer. 2008;122(7):1679–83.
12.
ChinS, LiuW, StorksonJ, HaY, ParizaM. Dietary sources of conjugated dienoic isomers of linoleic acid, a newly recognized class of anticarcinogens. Journal of food composition and analysis. 1992;5(3):185–97.
13.
ChoiJS, JungMH, ParkHS, SongJ. Effect of conjugated linoleic acid isomers on insulin resistance and mRNA levels of genes regulating energy metabolism in high-fat–fed rats. Nutr. 2004;20(11-12):1008–17.
14.
ParkY. Conjugated linoleic acid (CLA): Good or bad trans fat?J food Compos Analysis. 2009;22:S4–S12.
15.
Bassaganya-RieraJ, HontecillasR. Dietary CLA and n-3 PUFA in inflammatory bowel disease. Current Opin Clin Nutr Metabolic Care. 2010;13(5):569.
16.
ChanghuaL, JindongY, DefaL, LidanZ, ShiyanQ, JianjunX. Conjugated linoleic acid attenuates the production and gene expression of proinflammatory cytokines in weaned pigs challenged with lipopolysaccharide. J Nutr. 2005;135(2):239–44.
17.
BeluryMA, MahonA, BanniS. The conjugated linoleic acid (CLA) isomer, t10c12-CLA, is inversely associated with changes in body weight and serum leptin in subjects with type 2 diabetes mellitus. J Nutr. 2003;133(1):257S–60S.
18.
YamasakiM, ManshoK, OginoY, KasaiM, TachibanaH, YamadaK. Acute reduction of serum leptin level by dietary conjugated linoleic acid in Sprague-Dawley rats. J Nutr Biochem. 2000;11(9):467–71.
19.
MoloneyF, YeowT-P, MullenA, NolanJJ, RocheHM. Conjugated linoleic acid supplementation, insulin sensitivity, and lipoprotein metabolism in patients with type 2 diabetes mellitus. Am J Clin Nutr. 2004;80(4):887–95.
20.
SongH, GrantI, RotondoD, MohedeI, SattarN, HeysS, et al.Effect of CLA supplementation on immune function in young healthy volunteers. Eur J Clin Nutr. 2005;59(4):508–17.
21.
WasowiczW, NeveJ, PeretzA. Optimized steps in fluorometric determination of thiobarbituric acid-reactive substances in serum: importance of extraction pH and influence of sample preservation and storage. Clin Chem. 1993;39(12):2522–6.
22.
StattinP, PalmqvistR, SöderbergS, BiessyC, ArdnorB, HallmansG, et al.Plasma leptin and colorectal cancer risk: a prospective study in Northern Sweden. Oncol Report. 2003;10(6):2015–21.
23.
StattinP, LukanovaA, BiessyC, SöderbergS, PalmqvistR, KaaksR, et al.Obesity and colon cancer: does leptin provide a link?Inter J Cancer. 2004;109(1):149–52.
24.
DomnickM, DomnickM, WiebelitzK-R, BeerA-M. Evaluation of the effectiveness of a multimodal complementary medicine program for improving the quality of life of cancer patients during adjuvant radiotherapy and/or chemotherapy or outpatient aftercare. Oncol. 2017;93(2):83–91.
25.
JeongWK, BaekSK, KimMK, KwonSY, KimHS. Prognostic significance of tissue leptin expression in colorectal cancer patients. Annal Coloproctol. 2015;31(6):222.
26.
DonnellyS, WalshD, editors. The symptoms of advanced cancer. Sem Oncol; 1995.
27.
RISerusU, ArnerP, BrismarK, VessbyB. Treatment with dietary trans10cis12 conjugated linoleic acid causes isomer-specific insulin resistance in obese men with the metabolic syndrome. Diabetes Care. 2002;25(9):1516–21.
MedinaEA, HornWF, KeimNL, HavelPJ, BenitoP, KelleyDS, et al.Conjugated linoleic acid supplementation in humans: effects on circulating leptin concentrations and appetite. Lipids. 2000;35(7):783–8.
30.
ZhaoW-S, ZhaiJ-J, WangY-H, XieP-S, YinX-J, LiL-X, et al.Conjugated linoleic acid supplementation enhances antihypertensive effect of ramipril in Chinese patients with obesity-related hypertension. Am J Hyper. 2009;22(6):680–6.
31.
HaghighatdoostF, HaririM. Effect of conjugated linoleic acid supplementation on serum leptin concentration: a systematic review and meta-analysis. Endocrine Metabolic Immune Disorders Drug Targets. 2018;18(3):185–93.
32.
Esmaeili ShahmirzadiF, GhavamzadehS, ZamaniT. The Effect of Conjugated Linoleic Acid Supplementation on Body Composition, Serum Insulin and Leptin in Obese Adults. Arch Iran Med. 2019;22(5):255–61.
33.
PaikSS, JangS-M, JangK-S, LeeKH, ChoiD, JangSJ. Leptin expression correlates with favorable clinicopathologic phenotype and better prognosis in colorectal adenocarcinoma. Annal Surgical Oncol. 2009;16(2):297–303.
34.
MatsudaA, MatsutaniT, SasajimaK, FurukawaK, TajiriT, TamuraK, et al.Preoperative plasma adiponectin level is a risk factor for postoperative infection following colorectal cancer surgery. J Surgical Res. 2009;157(2):227–34.
35.
EftekhariMH, AliasghariF, Babaei-BeigiMA, HasanzadehJ. Effect of conjugated linoleic acid and omega-3 fatty acid supplementation on inflammatory and oxidative stress markers in atherosclerotic patients. ARYA Atherosclerosis. 2013;9(6):311.
36.
MahdaviR, FaramarziE, Mohammad-ZadehM, NasirimotlaghB, GhaemmaghamiSJ. Effects of conjugated linoleic acid supplementation on nutritional status, symptoms of eating problems and dietary intake in rectal cancer patients undergoing chemoradiotherapy. Current Topics Nutraceutical Res. 2013;11.
37.
SofiF, BuccioniA, CesariF, GoriAM, MinieriS, ManniniL, et al.Effects of a dairy product (pecorino cheese) naturally rich in cis-9, trans-11 conjugated linoleic acid on lipid, inflammatory and haemorheological variables: a dietary intervention study. Nutr Metab Cardiovas Dis. 2010;20(2):117–24.
38.
DupertuisYM, MeguidMM, PichardC. Colon cancer therapy: new perspectives of nutritional manipulations using polyunsaturated fatty acids. Current Opinion Clin Nutr Metabolic Care. 2007;10(4):427–32.
39.
DeveryR, MillerA, StantonC. Conjugated linoleic acid and oxidative behaviour in cancer cells. Portland Press Ltd.; 2001.
